Quote: They cannot promote an indication directly to consumers via DTC TV or internet ads until & unless they get label change.
This is not the case...and we will see new ads relating to R-I if and when positive results from the R-I trial come out...
The reason why they can only advertise the super high trig indication at present is because there is no accepted proof (truthful and non misleading information) that Vascepa lowers CVD event risk in statin patients and wont be until positive R-I result show it to be the case...After that FDA can not prevent the company from going forward and promoting those facts...To doctors or anyone else interested in the subject...
Market Data 
Markets 
AI
